DPP4 and type 2 diabetes mellitus: Dipeptidyl peptidase 4 inhibitors (DPP-4i), also known as gliptins, are oral antihyperglycemic drugs used in the pharmacological treatment of type 2 diabetes mellitus (T2DM).